0001209191-17-051332.txt : 20170905
0001209191-17-051332.hdr.sgml : 20170905
20170905163719
ACCESSION NUMBER: 0001209191-17-051332
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170901
FILED AS OF DATE: 20170905
DATE AS OF CHANGE: 20170905
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Saoud Jay
CENTRAL INDEX KEY: 0001716202
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36517
FILM NUMBER: 171069147
MAIL ADDRESS:
STREET 1: C/O MINERVA NEUROSCIENCES, INC.
STREET 2: 1601 TRAPELO ROAD, SUITE 284
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Minerva Neurosciences, Inc.
CENTRAL INDEX KEY: 0001598646
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 260784194
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1601 TRAPELO ROAD
STREET 2: SUITE 284
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-600-7373
MAIL ADDRESS:
STREET 1: 1601 TRAPELO ROAD
STREET 2: SUITE 284
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-09-01
0
0001598646
Minerva Neurosciences, Inc.
NERV
0001716202
Saoud Jay
MINERVA NEUROSCIENCES, INC.
1601 TRAPELO ROAD, SUITE 284
WALTHAM
MA
02451
0
1
0
0
SVP and Head of R&D
Employee Stock Option (Right to Buy)
6.45
2017-09-01
4
A
0
100000
0.00
A
2017-08-31
Common Stock
100000
100000
D
This option vested as to 25% of the shares on September 1, 2018 and then in quarterly installments over 3 years thereafter.
/s/ Matt Bartholomae, Attorney-in-Fact
2017-09-05